Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea
· Delayed Price · Currency is KRW 127,500
-3,500 (-2.67%)
Nov 18, 2024, 3:30 PM KST
Daewoong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 90,872 | 121,739 | 42,240 | 24,506 | 12,753 | 22,006 | Upgrade
|
| Depreciation & Amortization | 46,514 | 43,797 | 39,695 | 40,883 | 40,882 | 40,195 | Upgrade
|
| Loss (Gain) From Sale of Assets | -30,657 | -30,198 | -246.4 | 1,029 | -7,530 | -42.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | 14,421 | 2,372 | 5,219 | 2,109 | 8,103 | 9,322 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,078 | -130.67 | 4,112 | -8,308 | -2,622 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 2,689 | 1,443 | 374.54 | -257.52 | 355.37 | 22.16 | Upgrade
|
| Stock-Based Compensation | 550.7 | 1,618 | 1,841 | 2,005 | 1,195 | 943.21 | Upgrade
|
| Provision & Write-off of Bad Debts | 4,765 | 5,835 | 2,250 | 2,125 | 3,596 | 1,443 | Upgrade
|
| Other Operating Activities | 8,848 | 10,254 | -8,852 | 5,813 | 20,263 | -1,386 | Upgrade
|
| Change in Accounts Receivable | -42,938 | -478.7 | -23,193 | -20,692 | 44,176 | -6,733 | Upgrade
|
| Change in Inventory | 11,812 | - | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -8,747 | 16,597 | 12,408 | -8,373 | 1,865 | 12,600 | Upgrade
|
| Change in Unearned Revenue | 9,072 | - | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -23,553 | -36,838 | 42,368 | -844.34 | -22,056 | -20,771 | Upgrade
|
| Operating Cash Flow | 84,726 | 136,009 | 118,215 | 39,994 | 100,981 | 57,600 | Upgrade
|
| Operating Cash Flow Growth | -37.76% | 15.05% | 195.58% | -60.39% | 75.31% | 21.26% | Upgrade
|
| Capital Expenditures | -153,159 | -109,338 | -65,227 | -29,088 | -26,486 | -22,314 | Upgrade
|
| Sale of Property, Plant & Equipment | 652.23 | 1,446 | 483.47 | 257.43 | 17,700 | 139.87 | Upgrade
|
| Cash Acquisitions | -5,807 | -5,807 | - | - | - | - | Upgrade
|
| Divestitures | 45.6 | 45.6 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -62,406 | -46,289 | -46,826 | -45,633 | -30,781 | -26,296 | Upgrade
|
| Investment in Securities | -21,352 | -8,791 | 6,983 | -13,220 | -87,584 | -38,345 | Upgrade
|
| Other Investing Activities | 3,123 | 3,123 | 67.5 | - | -0 | -0 | Upgrade
|
| Investing Cash Flow | -238,913 | -165,621 | -106,872 | -87,683 | -127,152 | -85,605 | Upgrade
|
| Short-Term Debt Issued | - | 113,742 | 86,154 | 52,352 | 52,087 | 4,421 | Upgrade
|
| Long-Term Debt Issued | - | 65,000 | 149,683 | 108,357 | 91,561 | 200,000 | Upgrade
|
| Total Debt Issued | 367,509 | 178,742 | 235,837 | 160,709 | 143,647 | 204,421 | Upgrade
|
| Short-Term Debt Repaid | - | -87,934 | -1,212 | -53,258 | -4,357 | -2,565 | Upgrade
|
| Long-Term Debt Repaid | - | -94,201 | -201,593 | -91,675 | -91,702 | -201,324 | Upgrade
|
| Total Debt Repaid | -228,858 | -182,136 | -202,805 | -144,933 | -96,059 | -203,889 | Upgrade
|
| Net Debt Issued (Repaid) | 138,650 | -3,394 | 33,032 | 15,776 | 47,588 | 532.37 | Upgrade
|
| Issuance of Common Stock | - | 49,890 | - | 40,249 | 29,987 | - | Upgrade
|
| Dividends Paid | -7,922 | -7,278 | -8,066 | -6,458 | -6,193 | -6,193 | Upgrade
|
| Other Financing Activities | 97.8 | -0 | -9,450 | 656.41 | -4,796 | - | Upgrade
|
| Financing Cash Flow | 130,826 | 39,218 | 15,517 | 50,224 | 66,587 | -5,660 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1,462 | -1,052 | 184.47 | 1,073 | -211.65 | 425.5 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -24,823 | 8,555 | 27,044 | 3,608 | 40,205 | -33,240 | Upgrade
|
| Free Cash Flow | -68,433 | 26,671 | 52,988 | 10,906 | 74,495 | 35,286 | Upgrade
|
| Free Cash Flow Growth | - | -49.67% | 385.84% | -85.36% | 111.12% | - | Upgrade
|
| Free Cash Flow Margin | -4.89% | 1.94% | 4.14% | 0.95% | 7.06% | 3.17% | Upgrade
|
| Free Cash Flow Per Share | -5947.35 | 2334.57 | 4786.97 | 991.08 | 6986.64 | 3418.88 | Upgrade
|
| Cash Interest Paid | 17,208 | 16,604 | 11,480 | 9,839 | 10,667 | 10,390 | Upgrade
|
| Cash Income Tax Paid | 18,074 | 8,391 | 9,050 | 5,500 | 2,906 | 22,298 | Upgrade
|
| Levered Free Cash Flow | -115,411 | -18,388 | -44,864 | 44,982 | 50,247 | 2,234 | Upgrade
|
| Unlevered Free Cash Flow | -110,669 | -9,886 | -39,610 | 51,387 | 56,878 | 8,539 | Upgrade
|
| Change in Net Working Capital | 21,786 | -25,991 | 27,360 | -29,462 | -62,231 | 11,422 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.